Research
CLU supports research in a variety of areas in the growing phytotechnology industry. Members of our advisory board, instructors, and research affiliates have successfully launched IRB-approved clinical trials investigating a number of treatments for autism, seizure disorders, and migraines.
In addition to our ongoing clinical research, we have our own hemp grow operation that enables us to use state-of-the-art phytotechnology to research new strains and experiment with different product formulations that may one day save lives.
February 19, 2019
First US Clinical Study Assessing Hemp-Derived Cannabinoid Supplementation in Recovery from Traumatic Brain Injury to Begin in Colorado
TBI STUDY
Evaluation of Hemp-Derived Botanical Dietary Supplementation to Promote Healthy Brain Function During Recovery from Brain Injury.
If you have been diagnosed with a concussion or traumatic brain injury (TBI) and have experience using hemp-derived botanical food supplements you may be interested in participating in a study.
QUALIFICATIONS:
• You must be between the ages of 18 and 55
• You must have experience taking Hemp-derived supplements regularly (at least 1/week) for at least 1 month within the past year.
• You must be willing to visit our Denver office for testing during the hours of 9-5 PM and take an online survey (15 minutes) and undergo an electroencephalogram (EEG) and give saliva.
GOAL:
The goal of the study is to determine if Hemp-derived supplements that may or may not contain CBD and/or THC are effective for alleviating symptoms associated with TBI.
If interested contact us via the following encrypted email address: TBIstudy@protonmail.com
Sponsored by Clover Leaf University and the Flowering Hope Foundation.
